Robert W. Ross

Insider Reports History

Entity
Individual
Location
C/O Surface Oncology, 50 Hampshire St., 8 Th Floor, Cambridge, MA
Signature
/s/ Julia Walcott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert W. Ross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 25K Jun 14, 2024 Direct
Surface Oncology, Inc. Chief Executive Officer, Director Common Stock 0 $0.94 Sep 8, 2023 Direct
Surface Oncology, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 Sep 8, 2023 Direct

Insider Reports Filed by Robert W. Ross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
SURF Surface Oncology, Inc. Sep 8, 2023 2 $0 4 Sep 8, 2023 Chief Executive Officer, Director
SURF Surface Oncology, Inc. Aug 1, 2023 1 -$15.7K 4 Aug 11, 2023 Chief Executive Officer
XLO Xilio Therapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
SURF Surface Oncology, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Chief Executive Officer
SURF Surface Oncology, Inc. Aug 3, 2022 1 -$18.2K 4 Aug 5, 2022 Chief Executive Officer
XLO Xilio Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
XLO Xilio Therapeutics, Inc. Jun 15, 2022 0 $0 3 Jun 17, 2022 Director
SURF Surface Oncology, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Executive Officer
SURF Surface Oncology, Inc. Jul 21, 2021 1 -$204K 4 Jan 14, 2022 Chief Executive Officer